ResearcherUniversity of Arkansas for Medical SciencesActive in the last 2 years

Óscar Zúñiga

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1243-8603; OpenAlex author ID A5105937182. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1. Co-author DOI 10.1016/j.radonc.2024.110531 ↗
Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq. Co-author DOI 10.20517/cdr.2022.60 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Adam R. Wolfe · 2 shared papers, 2022–2024 · strength 0.50
- Paper Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wid… DOI 10.20517/cdr.2022.60 ↗
- Paper Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1. DOI 10.1016/j.radonc.2024.110531 ↗
Stetson Van Matre · 1 shared paper, 2024 · strength 0.24
- Paper Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1. DOI 10.1016/j.radonc.2024.110531 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.